Guoli Wei

948 total citations
46 papers, 717 citations indexed

About

Guoli Wei is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Guoli Wei has authored 46 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 15 papers in Molecular Biology and 8 papers in Pharmacology. Recurrent topics in Guoli Wei's work include Cancer Treatment and Pharmacology (12 papers), Plant-based Medicinal Research (5 papers) and Pharmacological Effects of Natural Compounds (4 papers). Guoli Wei is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Plant-based Medicinal Research (5 papers) and Pharmacological Effects of Natural Compounds (4 papers). Guoli Wei collaborates with scholars based in China, United States and Hong Kong. Guoli Wei's co-authors include Hao Wang, Yu Zhou, Shicai Ye, Weiyun Wu, Wenkai Tan, Xiao Feng, Lingchang Li, Jiege Huo, Jialin Yu and Feng Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Chemical Engineering Journal.

In The Last Decade

Guoli Wei

45 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guoli Wei China 13 406 266 155 71 64 46 717
Sayo Horibe Japan 12 359 0.9× 178 0.7× 144 0.9× 74 1.0× 79 1.2× 29 614
Ruifen Sun China 18 469 1.2× 378 1.4× 80 0.5× 51 0.7× 67 1.0× 35 740
Dongming Yan China 17 390 1.0× 273 1.0× 85 0.5× 71 1.0× 59 0.9× 64 782
Xiaoming Huang China 14 329 0.8× 166 0.6× 119 0.8× 48 0.7× 107 1.7× 54 616
Mengyao Sun China 15 414 1.0× 125 0.5× 97 0.6× 108 1.5× 76 1.2× 36 725
Sivapriya Ponnurangam United States 12 414 1.0× 188 0.7× 236 1.5× 35 0.5× 48 0.8× 15 681
Zhigang Sun China 18 556 1.4× 323 1.2× 122 0.8× 98 1.4× 94 1.5× 49 842
Gülçin Tezcan Türkiye 17 519 1.3× 322 1.2× 125 0.8× 31 0.4× 98 1.5× 64 828
Yu‐Chang Liu Taiwan 20 421 1.0× 160 0.6× 177 1.1× 66 0.9× 88 1.4× 34 748

Countries citing papers authored by Guoli Wei

Since Specialization
Citations

This map shows the geographic impact of Guoli Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoli Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoli Wei more than expected).

Fields of papers citing papers by Guoli Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoli Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoli Wei. The network helps show where Guoli Wei may publish in the future.

Co-authorship network of co-authors of Guoli Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Guoli Wei. A scholar is included among the top collaborators of Guoli Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoli Wei. Guoli Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhao, Bing, et al.. (2024). Bortezomib-induced peripheral neuropathy: Clinical features, molecular basis, and therapeutic approach. Critical Reviews in Oncology/Hematology. 197. 104353–104353. 12 indexed citations
3.
Ma, Nan, Guoli Wei, Jian Zhang, et al.. (2024). GOX mediated oxygen tolerance ATRP for detection of esophageal cancer biomarker miRNA-144. Chemical Engineering Journal. 495. 153543–153543. 8 indexed citations
4.
5.
Li, Sujuan, Sen Wang, Anping Zhang, et al.. (2024). Cucurbitacin IIa promotes the immunogenic cell death‑inducing effect of doxorubicin and modulates immune microenvironment in liver cancer. International Journal of Oncology. 64(4). 4 indexed citations
6.
Song, Jie, Sujuan Li, Lixia Luo, et al.. (2024). Combination of lipopolysaccharide and polygalacturonic acid exerts antitumor activity and augments anti-PD-L1 immunotherapy. International Journal of Biological Macromolecules. 281(Pt 1). 136390–136390. 4 indexed citations
7.
Wang, Wenjing, Guoli Wei, Yuqing Wang, et al.. (2023). Sodium alginate combined with oxymatrine ameliorates CCl4-induced chemical hepatic fibrosis in mice. International Immunopharmacology. 125(Pt A). 111144–111144. 9 indexed citations
8.
Hu, Miao, Ling Liu, Chen Chen, et al.. (2023). Complementary and alternative medicine in relation to chemotherapy-induced peripheral neuropathy: A narrative review. EXPLORE. 20(2). 181–187. 2 indexed citations
9.
Jin, Xin, Qing Yang, Guoli Wei, Jie Song, & Zhenhai Zhang. (2023). A simple self-assembling system of melittin for hepatoma treatment. Cancer Nanotechnology. 14(1). 5 indexed citations
10.
Hu, Miao, Ji Yi, Lingchang Li, et al.. (2022). Data mining analysis reveals key acupoints and meridians for the treatment of chemotherapy-induced peripheral neuropathy. EXPLORE. 19(1). 71–77. 6 indexed citations
11.
Wei, Guoli, et al.. (2022). Olfactory Dysfunction in Patients With Coronavirus Disease 2019: A Review. Frontiers in Neurology. 12. 783249–783249. 19 indexed citations
12.
Li, Yan, Jialin Yu, Miao Hu, et al.. (2022). A risk scoring system to predict the individual incidence of early-onset colorectal cancer. BMC Cancer. 22(1). 122–122. 14 indexed citations
13.
Lu, Hong, Chen Chen, Miao Hu, et al.. (2021). Diabetes mellitus as a risk factor for chemotherapy-induced peripheral neuropathy: a meta-analysis. Supportive Care in Cancer. 29(12). 7461–7469. 28 indexed citations
14.
Wei, Guoli, Liangjun Zhu, Lingjun Zhu, et al.. (2021). Preventive Efficacy and Safety of Yiqi-Wenjing-Fang Granules on Oxaliplatin-Induced Peripheral Neuropathy: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Evidence-based Complementary and Alternative Medicine. 2021. 1–9. 3 indexed citations
15.
Wei, Guoli, Ji Yi, Jialin Yu, et al.. (2021). A Prognostic Model Based on the Immune-Related lncRNAs in Colorectal Cancer. Frontiers in Genetics. 12. 658736–658736. 18 indexed citations
16.
Jiang, Ziyu, Lingchang Li, Jianan Chen, et al.. (2021). Human gut-microbiome interplay: Analysis of clinical studies for the emerging roles of diagnostic microbiology in inflammation, oncogenesis and cancer management. Infection Genetics and Evolution. 93. 104946–104946. 12 indexed citations
17.
Wei, Guoli, Yuzhu Ma, Jin‐Zhi Zhang, et al.. (2020). Exploring the Possible Mechanism and Drug Targets of Huang‐Qi‐Gui‐Zhi‐Wu‐Wu Decoction for the Treatment of Chemotherapy‐Induced Peripheral Neuropathy on Network Pharmacology. Evidence-based Complementary and Alternative Medicine. 2020(1). 2363262–2363262. 13 indexed citations
18.
Qian, Jun, Yi Cao, Lingchang Li, et al.. (2020). Tanshinone IIA induces autophagy in colon cancer cells through MEK/ERK/mTOR pathway. Translational Cancer Research. 9(11). 6919–6928. 12 indexed citations
19.
Li, Lingchang, Haiyan Wang, Guoli Wei, et al.. (2019). FuFangChangTai Decoction Activates Macrophages via Inducing Autophagy. Evidence-based Complementary and Alternative Medicine. 2019. 1–10. 6 indexed citations
20.
Wu, Weiyun, Zhuang Wang, Jian Liang, et al.. (2013). MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer. Molecular and Cellular Biochemistry. 388(1-2). 249–259. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sayo Horibe Breakdown of academic impact, for papers by Ruifen Sun Breakdown of academic impact, for papers by Dongming Yan Breakdown of academic impact, for papers by Xiaoming Huang Breakdown of academic impact, for papers by Mengyao Sun Breakdown of academic impact, for papers by Sivapriya Ponnurangam Breakdown of academic impact, for papers by Zhigang Sun Breakdown of academic impact, for papers by Gülçin Tezcan Breakdown of academic impact, for papers by Yu‐Chang Liu
Rankless by CCL
2026